ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Intra Cellular Therapies Inc

Intra Cellular Therapies Inc (ITCI)

131,24
-0,01
(-0,01%)
Geschlossen 08 März 10:00PM
131,24
-0,02
(-0,02%)
Nach Börsenschluss: 11:59PM
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
131,24
Gebot
131,17
Fragen
131,50
Volumen
1.259.934
131,21 Tagesbereich 131,315
63,30 52-Wochen-Bereich 131,36
Marktkapitalisierung
Handelsende
131,25
Handelsbeginn
131,30
Letzte Trade
1
@
131.27
Letzter Handelszeitpunkt
Finanzvolumen
US$ 165.370.659
VWAP
131,2534
Durchschnittliches Volumen (3 Mio.)
3.038.994
Ausgegebene Aktien
106.327.952
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-186,90
Gewinn pro Aktie (EPS)
-0,7
Erlöse
680,85M
Nettogewinn
-74,68M

Über Intra Cellular Therapies Inc

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-... Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Intra Cellular Therapies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ITCI. The last closing price for Intra Cellular Therapies was US$131,25. Over the last year, Intra Cellular Therapies shares have traded in a share price range of US$ 63,30 to US$ 131,36.

Intra Cellular Therapies currently has 106.327.952 shares in issue. The market capitalisation of Intra Cellular Therapies is US$13,96 billion. Intra Cellular Therapies has a price to earnings ratio (PE ratio) of -186.90.

ITCI Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
12.842.21183800623128.4131.36128.063089426130.95869799CS
44.093.21667322061127.15131.36127.012176417129.14163205CS
1247.957.475401967883.34131.3680.8253038994124.36646113CS
2657.3877.687516923973.86131.3670.91643499116.470681CS
5264.8197.561342766866.43131.3663.3130063299.44363879CS
15676.39139.27073837754.85131.3642.0194954076.04175561CS
260111.3558.17452357119.94131.3610.93591458859.30040522CS

ITCI - Frequently Asked Questions (FAQ)

What is the current Intra Cellular Therapies share price?
The current share price of Intra Cellular Therapies is US$ 131,24
How many Intra Cellular Therapies shares are in issue?
Intra Cellular Therapies has 106.327.952 shares in issue
What is the market cap of Intra Cellular Therapies?
The market capitalisation of Intra Cellular Therapies is USD 13,96B
What is the 1 year trading range for Intra Cellular Therapies share price?
Intra Cellular Therapies has traded in the range of US$ 63,30 to US$ 131,36 during the past year
What is the PE ratio of Intra Cellular Therapies?
The price to earnings ratio of Intra Cellular Therapies is -186,9
What is the cash to sales ratio of Intra Cellular Therapies?
The cash to sales ratio of Intra Cellular Therapies is 20,5
What is the reporting currency for Intra Cellular Therapies?
Intra Cellular Therapies reports financial results in USD
What is the latest annual turnover for Intra Cellular Therapies?
The latest annual turnover of Intra Cellular Therapies is USD 680,85M
What is the latest annual profit for Intra Cellular Therapies?
The latest annual profit of Intra Cellular Therapies is USD -74,68M
What is the registered address of Intra Cellular Therapies?
The registered address for Intra Cellular Therapies is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Intra Cellular Therapies website address?
The website address for Intra Cellular Therapies is www.intracellulartherapies.com
Which industry sector does Intra Cellular Therapies operate in?
Intra Cellular Therapies operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M

ITCI Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock